Duvera Therapy Pllc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3555 Regent St, Richland, WA 99352 Phone: 262-327-1022 |
Tessa Beloved Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1549 Georgia Ave, Richland, WA 99352 Phone: 509-736-1062 Fax: 509-737-8492 |
Tiara Cox Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 925 Stevens Dr Ste 1e, Richland, WA 99352 Phone: 509-942-8474 Fax: 509-356-9154 |
Cody Yecha, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Bellerive Dr Apt Y-246, Richland, WA 99352 Phone: 509-675-1222 |
Stephanie Holt, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1950 Keene Rd Bldg M, Richland, WA 99352 Phone: 509-713-7800 Fax: 509-713-7800 |
Megan Dennis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1745 Pike Ave, Richland, WA 99354 Phone: 509-946-8095 Fax: 509-946-5109 |
Kristine E Sumner, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1549 Georgia Ave, Richland, WA 99352 Phone: 509-735-1062 Fax: 509-737-8492 |
Emily Susan Piatt, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1549 Georgia Avenue Se, Suite A, Richland, WA 99352 Phone: 509-735-1062 Fax: 509-737-8492 |
Kristy Barber Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 615 Snow Ave, Richland, WA 99352 Phone: 509-967-6308 |
News Archive
Two brothers have been cured of their sickle cell disease at the University of Illinois Hospital & Health Sciences System using a relatively uncommon type of stem cell transplant that is performed without chemotherapy.
A new study appearing online today from the American Journal of Psychiatry finds that ketamine's acute antidepressant effect requires opioid system activation, the first time that a receptor site has been shown in humans to be necessary for any antidepressant's mechanism of action.
The Federal Aviation Administration has announced that it will issue new guidance for aviation medical examiners (AMEs) regarding the screening and treatment of obstructive sleep apnea (OSA) in commercial pilots. The new guidance, which hopes to treat pilots fairly while at the same time increasing aviation safety, was created and approved with input from the industry, Congress, and the National Transportation Safety Board (NTSB).
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced interim results from a Phase I clinical trial of its investigational drug candidate, recombinant human Interleukin-7 (CYT107), in the treatment of post-transplant patients with T-cell depleted (TCD) bone marrow or peripheral blood stem cell transplants.
› Verified 8 days ago